MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. Its tests provide hospitals, labs, clinics, and individuals with rapid diagnosis for diseases, including human immunodeficiency virus and hepatitis C. It offers its tests under the Reveala, Multiplo, and Miriad brands. The company was founded by Hermes Hermes Chan and Carlina Hui in 1993 and is headquartered in Halifax, Canada.